Skip to content
Home / News |

Genedrive Shares Plunged 9.56% Today, Here’s Why

genedrive logo
Simon Mugo

Shares of Genedrive PLC (LON: GDR) today fell 9.56% despite the company reporting a significant milestone for its coronavirus testing kit.

The company reported that ist 96 SARS-CoV-2 testing equipment had been verified to work with its collaboration partner Beckman Coulter Life Sciences’ RNA extraction equipment, which can now be used in Genedrive’s workflow.

The next stage for the two companies is to release the solution in stages starting with swab-based tests followed by saliva tests.

X testing X
WELCOME BONUS - Free Share Bundle When You Invest £50! Get up to £500 cashback for investing with IG.
Invest in 15,000+ shares and ETFs. Open an account now, invest at least £50, and you’ll get a free share bundle worth between £40 and £200. T&Cs apply.
5.0
Open Account Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 68% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.

However, the stock’s selloff could have been triggered by David Budd’s comments that it will take some time before the saliva tests can get approval from the US Food & Drug Administration given the strict guidelines imposed by the regulator.

Gendedrive’s CEO, David Budd explained that: “Our initial US evaluation site is currently being installed following the completion of our internal validation studies, after which they will validate the end-to-end solution as required. We will obtain regulatory approvals prior to a final solution release.”

Genedrive share price

Tradingview chart of Genedrive share price 25092020

Genedrive shares today fell 9.56% to trade at 123p having dropped from yesterday’s closing price of 136p.

People who read this also read:

Simon Mugo
Simon Mugo
Contributor

Simon ist Autor und Analyst für den Bereich Finanzwesen und blickt auf über sechs Jahre professionelle Erfahrung als Trader zurück. Er absolvierte einen Bachelor in Mathematik und Informatik und hat eine Leidenschaft für die Finanzmärkte. Simon handelt FX, Rohstoffe und Aktien. Er konzentriert sich auf Price Action Trading.